Back to Journals » Drug Design, Development and Therapy » Volume 7

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin

Total article views   HTML views PDF downloads Totals
21,033 Dovepress* 13,091+ 3,589 16,680
PubMed Central* 7,942 2,920 10,862
Totals 21,033 6,509 27,542
*Since 17 September 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar